NIFTY 50▲25,415.80
38.25 (0.15%)
SENSEX▲83,184.80
236.57 (0.29%)
NIFTY BANK▲53,037.60
287.20 (0.54%)
TATA MOTORS▲967.00
4.95 (0.51%)
SUZLON ENERGY▲80.97
0.15 (0.19%)
INDIAN RAILWAY FINANCE CORP▼155.25
-3.31 (-2.09%)
TATA STEEL▼149.54
-1.06 (-0.70%)
TATA POWER▼439.60
-1.00 (-0.23%)
RAIL VIKAS NIGAM▼510.20
-18.40 (-3.48%)
RELIANCE INDUSTRIES▲2,939.35
12.45 (0.43%)
INDIAN RENEWABLE ENERGY▲230.01
2.62 (1.15%)
VODAFONE IDEA▼10.38
-2.52 (-19.53%)
ZOMATO▲278.85
3.00 (1.09%)
ADANI POWER▼649.60
-2.10 (-0.32%)
YES BANK▼22.95
-0.37 (-1.59%)
RELIANCE POWER▲34.61
1.64 (4.97%)
NHPC▼92.43
-1.96 (-2.08%)
STATE BANK OF INDIA▼789.95
-2.80 (-0.35%)
HDFC BANK▲1,708.50
13.70 (0.81%)
JIO FIN SERVICES LTD▼346.65
-0.25 (-0.07%)
ADANI PORT & SEZ▼1,408.20
-20.60 (-1.44%)
OLA ELECTRIC MOBILITY LTD▼111.67
-5.28 (-4.51%)
BHARAT ELECTRONICS▼272.70
-10.15 (-3.59%)
GTL INFRA▼2.37
-0.12 (-4.82%)
INDIAN OIL CORP▼165.04
-3.41 (-2.02%)
MRF▲1,36,347.60
2104.90 (1.57%)
INDIAN RAILWAY TOURISM CORP▼883.65
-21.90 (-2.42%)
RATTANINDIA POWER▼14.95
-0.39 (-2.54%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. stocks list
    apple-store
  4. ORCHID PHARMA
stock logo

100% Buy

ORCHID PHARMA Share Price

ORCHPHARMA

₹1,361.65-₹41.45 (-2.95%) TodayLast updated on 19 Sep, 2024 | 15:57 IST
Please wait...

  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹7,116 Crs

Open

₹1,417.15

Close

₹1,403.10

Circuit range

₹1,633.95 - ₹1,089.35

Day range

₹1,339.60 - ₹1,434.45

Year range

₹432.05 - ₹1,590.00

Volume

79,322

Avg. traded

₹1,367.56

Revenue (12m)

₹881 Crs

ORCHID PHARMAOrchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

ORCHID PHARMA Key indicators

arrow

52 week high

₹1,590.00

52 week low

₹432.05

P/E ratio

61.31

P/B ratio

5.95

ROE

9.72%

ROCE

8.96%

Dividend yield

--

Debt/Equity ratio

0.11

EPS

18.68

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 3 experts in the last 7 days

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

17.26%

Net profit margin

11.56%

ROE

9.72%

ROA

6.83%

ROCE

8.96%

Learn more

ORCHID PHARMA Share Price history

arrow
DayOpenCloseDay’s change
Thu, Sep 19 2024
₹1,417.15
₹1,361.65
-2.95%
Wed, Sep 18 2024
₹1,425.80
₹1,403.10
-2.37%
Tue, Sep 17 2024
₹1,483.50
₹1,437.15
-2.89%
Mon, Sep 16 2024
₹1,545.00
₹1,479.85
-3.34%
Fri, Sep 13 2024
₹1,531.25
₹1,531.00
+0.99%
Thu, Sep 12 2024
₹1,520.00
₹1,516.05
+0.19%
Wed, Sep 11 2024
₹1,515.70
₹1,513.10
+0.08%
Tue, Sep 10 2024
₹1,498.95
₹1,511.90
+2.11%

Shareholding info

arrow

Promoters (69.84%)

Mutual Funds (16.91%)

Retail and other (9.81%)

Foreign institutions-FII (1.42%)

Other domestic institutions (2.02%)

Promoters

Learn more

Frequently asked questions